CEL-SCI Corp. (CVM)
1.04
-0.06
(-5.45%)
USD |
NYAM |
Jun 18, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
CEL-SCI Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0549M |
| September 30, 2021 | 0.0549M |
| June 30, 2021 | 0.0549M |
| March 31, 2021 | 0.0549M |
| December 31, 2020 | 0.0549M |
| September 30, 2020 | 0.0549M |
| June 30, 2020 | 0.255M |
| March 31, 2020 | 0.0623M |
| December 31, 2019 | 0.091M |
| September 30, 2019 | 0.0628M |
| June 30, 2019 | 0.1183M |
| March 31, 2019 | 0.1232M |
| December 31, 2018 | 0.1288M |
| September 30, 2018 | 0.1187M |
| June 30, 2018 | 0.1197M |
| March 31, 2018 | 0.1368M |
| December 31, 2017 | 0.0476M |
| September 30, 2017 | 0.2185M |
| June 30, 2017 | 0.2717M |
| March 31, 2017 | 0.0043M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.0041M |
| September 30, 2016 | 0.3945M |
| June 30, 2016 | 0.7907M |
| March 31, 2016 | 0.6548M |
| December 31, 2015 | 0.3783M |
| September 30, 2015 | 0.0872M |
| June 30, 2015 | 0.1585M |
| March 31, 2015 | 0.0374M |
| December 31, 2014 | |
| September 30, 2014 | 0.0818M |
| June 30, 2014 | 0.0804M |
| March 31, 2014 | 0.1349M |
| December 31, 2013 | 0.0459M |
| September 30, 2013 | 0.0743M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 0.1586M |
| June 30, 2012 | 0.0257M |
| March 31, 2012 | 0.1015M |
| December 31, 2011 | 0.0086M |
| September 30, 2011 | 0.4573M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Agenus, Inc. | 46.56M |
| Amgen, Inc. | 9.138B |
| Anika Therapeutics, Inc. | 25.77M |
| BioCryst Pharmaceuticals, Inc. | 109.27M |
| Imunon, Inc. | -- |